comparemela.com

Amina Odidi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Intellipharmaceutics International : MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED AUGUST 31, 2023 - Form 6-K -October 16, 2023 at 05:27 pm EDT

MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED AUGUST 31, 2023 The.

United statesNorthern samarNew yorkRepublic ofAmina odidiVictor romitaChristopher pearceAnstalt alphaIsa odidiSteven boydPurdue pharmaHealth canadaCanadian chartered bankDrug administrationUs securities exchangePf laboratories inc

Intellipharmaceutics International : Reports Director Election Results - Form 6-K -October 06, 2023 at 11:36 am EDT

Intellipharmaceutics Reports Director Election Results Toronto, Ontario, September 14, 2023, Intellipharmaceutics International Inc. , a pharmaceutical company specializing in.

United statesShawn grahamNorman bettsIsa odidiAmina odidiSee the company report on votingCompany contactIntellipharmaceutics international incIntellipharmaceutics reports director electionIntellipharmaceutics internationalManagement information circularVoting resultsPoint of divergence drug delivery systemSecurities act

Intellipharmaceutics International : Appointment of Proxyholder - Form 6-K -October 06, 2023 at 11:36 am EDT

Appointment of Proxyholder I/We, being holder of common shares of Intellipharmaceutics International Inc. , hereby appoint of Dr. Amina Odidi, President and Chief Operating.

United statesIsa odidiPatrick yatAmina odidiShawn grahamNorman bettsTrust companyMeeting of shareholders the companyNational clubAnalytical servicesCompany of theIntellipharmaceutics international incMeeting of shareholders intellipharmaceutics international incIntellipharmaceutics internationalChief operating officerAnnual meeting

Intellipharmaceutics International : MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Form 6-K -September 26, 2023 at 05:28 pm EDT

MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS For the THREE MONTHS ENDED February 28, 2023 The following.

Northern samarUnited statesRepublic ofNew yorkIsa odidiAmina odidiPurdue pharmaChristopher pearceSteven boydVictor romitaAnstalt alphaProgram feeIntellipharmaceutics ltdA companyUs district courtCompany registration statement on form

Intellipharmaceutics Reports Director Election Results

Intellipharmaceutics Reports Director Election Results

United statesIsa odidiNorman bettsAmina odidiShawn grahamIntellipharmaceutics international inc isa odidichief executive officerSee the company report on votingIntellipharmaceutics international incCompany contactNews networkIntellipharmaceutics internationalManagement information circularNomineevotes forVoting resultsPoint of divergence drug delivery systemStatement regarding forward looking information

vimarsana © 2020. All Rights Reserved.